STAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
STAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cells
Authors
Keywords
-
Journal
DARU-Journal of Pharmaceutical Sciences
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-16
DOI
10.1007/s40199-020-00326-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Natural compound inducers of immunogenic cell death
- (2019) Marc Diederich ARCHIVES OF PHARMACAL RESEARCH
- Delivery of natural phenolic compounds for the potential treatment of lung cancer
- (2019) Ashley G. Muller et al. DARU-Journal of Pharmaceutical Sciences
- Immunogenic cell death in cancer therapy: Present and emerging inducers
- (2019) Jingyi Zhou et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Stress-induced cellular responses in immunogenic cell death: Implications for cancer immunotherapy
- (2018) Flavia Radogna et al. BIOCHEMICAL PHARMACOLOGY
- The role of STAT3 in leading the crosstalk between human cancers and the immune system
- (2018) Yu Wang et al. CANCER LETTERS
- Immunogenic Apoptosis as a Novel Tool for Anticancer Vaccine Development
- (2018) Barbara Montico et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Adjuvant therapy with stattic enriches the anti-proliferative effect of doxorubicin in human ZR-75-1 breast cancer cells via arresting cell cycle and inducing apoptosis
- (2018) Fatemeh khaki-khatibi et al. BIOMEDICINE & PHARMACOTHERAPY
- Self-Associating Poly(ethylene oxide)-block-poly(α-carboxyl-ε-caprolactone) Drug Conjugates for the Delivery of STAT3 Inhibitor JSI-124: Potential Application in Cancer Immunotherapy
- (2017) Shyam M. Garg et al. MOLECULAR PHARMACEUTICS
- Induction of immunogenic cell death of tumors by newly synthesized heterocyclic quinone derivative
- (2017) Keum-joo Son et al. PLoS One
- High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy
- (2016) Suresh Gopi Kalathil et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells
- (2015) Heng Yang et al. CANCER RESEARCH
- Impact of high glucose on metastasis of colon cancer cells
- (2015) Cheng-Yao Lin et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy
- (2015) Jonathan Pol et al. OncoImmunology
- IL-12 Produced by Dendritic Cells Augments CD8+ T Cell Activation through the Production of the Chemokines CCL1 and CCL17
- (2014) C. J. Henry et al. JOURNAL OF IMMUNOLOGY
- The effects of cichorium intybus extract on the maturation and activity of dendritic cells
- (2014) Mohammad Karimi et al. DARU-Journal of Pharmaceutical Sciences
- TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells
- (2013) Hongliang Fang et al. Cellular & Molecular Immunology
- Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy
- (2013) Christel Devaud et al. OncoImmunology
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Silencing of the transcription factor STAT3 sensitizes lung cancer cells to DNA damaging drugs, but not to TNFα- and NK cytotoxicity
- (2012) Dorota W. Kulesza et al. EXPERIMENTAL CELL RESEARCH
- STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers
- (2012) XIAOCHUN WANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy
- (2011) Oliver Kepp et al. CANCER AND METASTASIS REVIEWS
- Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors
- (2011) S. R. Mattarollo et al. CANCER RESEARCH
- Cytokines in Cancer Immunotherapy
- (2011) Sylvia Lee et al. Cancers
- Tumor Cell Death and ATP Release Prime Dendritic Cells and Efficient Anticancer Immunity
- (2010) L. Aymeric et al. CANCER RESEARCH
- Immunogenic chemotherapy with cyclophosphamide and doxorubicin against established murine carcinoma
- (2009) Miki Tongu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immunogenic death of colon cancer cells treated with oxaliplatin
- (2009) A Tesniere et al. ONCOGENE
- The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death
- (2008) T Panaretakis et al. CELL DEATH AND DIFFERENTIATION
- Immunogenic cancer cell death: a key-lock paradigm
- (2008) Antoine Tesniere et al. CURRENT OPINION IN IMMUNOLOGY
- Immune modulation by melanoma-derived factors
- (2008) Dan Ilkovitch et al. EXPERIMENTAL DERMATOLOGY
- Targeting STAT3 in cancer: how successful are we?
- (2008) Peibin Yue et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now